AcquisitionOther
Silverback Therapeutics, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Silverback Therapeutics, Inc. -> target · $280 Million
Our team at ARS believes that neffy ® can add significant clinical value to the community by providing an alternative to the currently approved injection devices for patients and caregivers that either do not carry, avoid using or hesitate to use their epi
Open source record (SEC) ↗